Biotech Values

[ghmm]

I agree with what you say about smaller biotechs tending to rush things. Its great if it works but seems much more risky and other then a few (ERT's) can think of repeat successes.

For what its worth, while the individual HALO trials were short what is it about 10 or so Phase 1/2 studies a bunch of short trials can still take a while .